# reload+after+2024-01-22 21:43:37.289006
address1§Bellevue Centre
address2§Suite 300 235 -15th Street
city§West Vancouver
state§BC
zip§V7T 2X1
country§Canada
phone§604 921 1810
fax§604 921 1898
website§https://briacell.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§BriaCell Therapeutics Corp., an immuno-oncology-focused biotechnology company, engages in developing immunotherapies for the management of cancer. Its lead drug candidate is Bria-IMT, a whole-cell cancer vaccine that is in Phase I/IIa clinical trials in combination with the immunotherapy development candidates retifanlimab. The company also develops Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test that determines the patients' HLA types. It has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
fullTimeEmployees§16
companyOfficers§[{'maxAge': 1, 'name': 'Dr. William V. Williams M.D.', 'age': 67, 'title': 'CEO, President & Director', 'yearBorn': 1956, 'fiscalYear': 2023, 'totalPay': 785305, 'exercisedValue': 0, 'unexercisedValue': 513495}, {'maxAge': 1, 'name': 'Mr. Gadi  Levin B.Com., C.A., CPA, M.B.A.', 'age': 50, 'title': 'CFO & Corporate Secretary', 'yearBorn': 1973, 'fiscalYear': 2023, 'totalPay': 304465, 'exercisedValue': 0, 'unexercisedValue': 211106}, {'maxAge': 1, 'name': 'Dr. Miguel A. Lopez-Lago Ph.D.', 'age': 54, 'title': 'Chief Scientific Officer', 'yearBorn': 1969, 'fiscalYear': 2023, 'totalPay': 298897, 'exercisedValue': 0, 'unexercisedValue': 2598}, {'maxAge': 1, 'name': 'Dr. Giuseppe  Del Priore M.D., M.P.H., MPH', 'age': 61, 'title': 'Chief Medical Officer', 'yearBorn': 1962, 'fiscalYear': 2023, 'totalPay': 492505, 'exercisedValue': 0, 'unexercisedValue': 2598}, {'maxAge': 1, 'name': 'Dr. Charles Louis Wiseman FACP, M.D.', 'age': 77, 'title': 'Founder, Principal Research Advisor & Member of Scientific Advisory Board', 'yearBorn': 1946, 'fiscalYear': 2023, 'totalPay': 241138, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1703980800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§1.735
currency§USD
dateShortInterest§1702598400
forwardEps§-1.05
exchange§NCM
quoteType§EQUITY
shortName§BriaCell Therapeutics Corp.
longName§BriaCell Therapeutics Corp.
firstTradeDateEpochUtc§1331731800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§4582bc39-2d8c-30ab-8663-2245a7a6ffd9
gmtOffSetMilliseconds§-18000000
targetHighPrice§18.0
targetLowPrice§15.0
targetMeanPrice§16.5
targetMedianPrice§16.5
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§2
quickRatio§13.06
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
